这些药物由“临床资料公司”(Clinical DataInc .)制造，是一个5 - HT再摄取抑制剂与5ht1a激动剂的化合物。
The medication, manufactured by Clinical Data Inc., is a combined serotonin reuptake inhibitor and 5ht1a agonist.
为了合成新的化合物，化学家们总是按照古老的做法，把各种反应物放在一起搅拌，再对这样得到的混合物进行加热。
To synthesize new compounds, chemists have followed the time-honored recipe of stirring together the reactants and heating the resulting mixture.
药物化学家们再对筛选出来的化合物结构进行研究，设计出药效提高而没有毒性的化合物，然后进行动物试验及临床试验。
Medicinal chemists would then study the structures of compounds that pass the screen and design compounds that enhance the activity without being toxic. Animal and human trials would follow.
吡喃酮类化合物在飞蓬属植物中广泛存并且显示了强的治疗脑中风及调节血压的作用，以及对缺血再灌注损伤的保护作用。
Pyran Derivatives is widespread in erigeron, And the treatment showed a strong stroke, And the regulation of blood pressure, the protection effect For ischemia-reperfusion injury.
目的探讨化合物N - 2 2 11对大鼠局灶性脑缺血再灌注损伤的保护作用。
Objective Aim To investigate the protective effect of compound N-2211 on cerebral ischemia-reperfusion injury in rats.
目的探讨化合物N - 2 2 11对大鼠局灶性脑缺血再灌注损伤的保护作用。
Objective Aim To investigate the protective effect of compound N-2211 on cerebral ischemia-reperfusion injury in rats.
应用推荐